ResMed Inc. (LON: 0KW4)

London flag London · Delayed Price · Currency is GBP · Price in USD
234.65
+3.58 (1.55%)
Dec 20, 2024, 7:13 PM BST
35.81%
Market Cap 27.69B
Revenue (ttm) 3.59B
Net Income (ttm) 830.32M
Shares Out n/a
EPS (ttm) 5.63
PE Ratio 33.35
Forward PE n/a
Dividend 1.58 (0.68%)
Ex-Dividend Date Nov 7, 2024
Volume 279
Open 233.58
Previous Close 231.07
Day's Range 231.00 - 238.21
52-Week Range 132.67 - 240.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 23, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1989
Employees 9,980
Stock Exchange London Stock Exchange
Ticker Symbol 0KW4
Full Company Profile

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Financial numbers in USD Financial Statements

News

Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?

Eli Lilly gained FDA approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.

2 days ago - Investor's Business Daily

ResMed launches head strap for Apple's Vision Pro system

ResMed (RMD) introduces Kontor Head Strap for Apple Vision Pro, offering comfort and stability with modular counterweights for extended wear time. Read more here.

10 days ago - Seeking Alpha

ResMed Inc (RMD) CFO Brett Sandercock Sells 1,000 Shares

ResMed Inc (RMD) CFO Brett Sandercock Sells 1,000 Shares

11 days ago - GuruFocus

Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD)

Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RMD)

17 days ago - GuruFocus

Canada Sleep Apnea Devices Market Research Report 2024: Opportunities and Forecasts to 2029 Featuring Braebon Medical, VitalAire, FPM Solutions, SomnoMed, and ResMed

Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Canada Sleep Apnea Devices Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's offeri...

19 days ago - GlobeNewsWire

My Top 15 High-Growth Dividend Stocks For December 2024

The SPDR S&P 500 ETF Trust posted a strong gain of 5.96% in November, resuming its strong run in 2024. The Top 15 dividend growth stocks for December 2024 offer an average dividend yield of 1.2% and a...

21 days ago - Seeking Alpha

Insider Transaction: Michael J Farrell Sells $499K Worth Of ResMed Shares

It was reported on November 27, that Michael J Farrell , Chief Executive Officer at ResMed (NYSE: RMD) executed a significant insider sell, according to an SEC filing. What Happened: Farrell's decisi...

24 days ago - Benzinga

ResMed: Solid Execution, Pricey Valuation

27 days ago - Seeking Alpha

Insider Sell: Justin Leong Sells 6,160 Shares of ResMed Inc (RMD)

Insider Sell: Justin Leong Sells 6,160 Shares of ResMed Inc (RMD)

27 days ago - GuruFocus

ResMed Inc (RMD)'s Winning Formula: Financial Metrics and Competitive Strengths

ResMed Inc (RMD)'s Winning Formula: Financial Metrics and Competitive Strengths

4 weeks ago - GuruFocus

ResMed expands Singapore operations to address obstructive sleep conditions

Mick Farrell, CEO of medical equipment maker ResMed, says the company is pouring "tens of millions of dollars" into expanding its Singapore operations as it aims to help 500 million people sleep bette...

4 weeks ago - CNBC

ResMed Announces Participation in the UBS Global Healthcare Conference

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will particip...

6 weeks ago - GlobeNewsWire

My Top 15 High-Growth Dividend Stocks For November 2024

The SPDR S&P 500 ETF Trust posted a loss of 0.89% in October, putting a pause on its strong run in 2024. The Top 15 dividend growth stocks for November 2024 offer an average dividend yield of 1.24% an...

7 weeks ago - Seeking Alpha

ResMed CEO On Earnings, Sleep Apnea

ResMed (RMD) CEO Mick Farrell joins Morning Trade Live to discuss the company's latest earnings beat. ResMed primarily focuses on sleep apnea and COPD.

7 weeks ago - Schwab Network

Sleep Apnea Device Maker ResMed Is A Durable MedTech, With Positive Fundamentals, Says Analyst

On Thursday, ResMed Inc RMD reported first-quarter adjusted EPS of $2.20, up 34% year over year, beating the consensus of $2.04.

2 months ago - Benzinga

ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript

ResMed Inc. (NYSE:RMD) Q1 2025 Earnings Conference Call October 24, 2024 4:30 PM ET Company Participants Amy Wakeham - Chief Investor Relations Officer Michael Farrell - Chairman and Chief Executive ...

2 months ago - Seeking Alpha

ResMed beats quarterly profit estimates on strong demand for its sleep apnea devices

ResMed beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its devices used for sleep apnea treatment.

2 months ago - Reuters

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, O...

2 months ago - GlobeNewsWire

My Top 15 High Growth Dividend Stocks For October 2024

The SPDR S&P 500 ETF Trust posted a gain of 2.10% in September as it continues marching on in 2024. The Top 15 dividend growth stocks for October 2024 offer an average dividend yield of 1.05% and appe...

2 months ago - Seeking Alpha

ResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns

NEW YORK and SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today unveiled its 2030 Strategy to drive growth, profitability, and shareholder returns at an Investor Day in N...

2 months ago - GlobeNewsWire

UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir ™ consumer app with Apple and Android s...

3 months ago - GlobeNewsWire

UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

3 months ago - GlobeNewsWire

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health

3 months ago - GlobeNewsWire

ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

ResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by integrating its leading myAir ™ consumer app with Apple and Android s...

3 months ago - GlobeNewsWire